Eswatini
66
(50-86), HBV-related deaths, 2017
5.9
per 100,000, HBV death rate, 2017
37%
Liver cancer deaths attributable to HBV, 2017
66
(52-84), HCV-related deaths, 2017
5.9
per 100,000, HCV death rate, 2017
25%
Liver cancer deaths attributable to HCV, 2017
Eligible
for HBV generic medication
Eligible
for HCV generic medication